Page last updated: 2024-09-02

ta 0910 and levodopa

ta 0910 has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(ta 0910)
Trials
(ta 0910)
Recent Studies (post-2010)
(ta 0910)
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
6421417,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomyta 0910 (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asahi, T; Fukuchi, I; Kawashima, K; Kawashima, Y; Kinoshita, K; Matsuoka, Y; Yamamura, M1

Other Studies

1 other study(ies) available for ta 0910 and levodopa

ArticleYear
Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:4

    Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Thyrotropin-Releasing Hormone

1998